{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:13:13Z","timestamp":1790791993784,"version":"4.1.0"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["2000111201"],"award-info":[{"award-number":["2000111201"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.critrevonc.2018.12.007","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T11:55:13Z","timestamp":1547639713000},"page":"115-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Cancer of the anal region"],"prefix":"10.1016","volume":"135","author":[{"given":"Francesca","family":"Valvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Ciurlia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Avuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Doci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Ducreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicitas","family":"Roelofsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Trama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Wittekind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Bosset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2018.12.007_bib0005","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0002-9343(89)80702-8","article-title":"Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal","volume":"87","author":"Ajani","year":"1989","journal-title":"Am. J. Med."},{"issue":"16","key":"10.1016\/j.critrevonc.2018.12.007_bib0010","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.critrevonc.2018.12.007_bib0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<405::AID-CNCR7>3.0.CO;2-Q","article-title":"Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment","volume":"86","author":"Allal","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0020","series-title":"Cancer Staging Manual","author":"American Joint Committee on Cancer","year":"2010"},{"issue":"6","key":"10.1016\/j.critrevonc.2018.12.007_bib0025","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1037\/0022-006X.57.6.683","article-title":"Controlled prospective longitudinal study of women with cancer: I. Sexual functioning outcomes","volume":"57","author":"Andersen","year":"1989","journal-title":"J. Consult. Clin. Psychol."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.12.007_bib0030","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1071\/SH03019","article-title":"Is screening for anal cancer warranted in homosexual men?","volume":"1","author":"Anderson","year":"2004","journal-title":"Sex. Health"},{"issue":"9034","key":"10.1016\/j.critrevonc.2018.12.007_bib0035","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","article-title":"Epidermoid anal cancer: results from the UKCCCR randomized trial of radiotherapy alone versus radiotherapy, 5- fluorouracil, and mitomycin. UKCCCR Anal Cancer trial Working Party. UK Co-ordinating Committee on Cancer research","volume":"348","author":"Arnott","year":"1996","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.critrevonc.2018.12.007_bib0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jso.20014","article-title":"Inferiorly based rectus abdominis myocutaneous flaps in surgical oncology: indications, technique, and experience in 37 patients","volume":"85","author":"Bakx","year":"2004","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0045","first-page":"311","article-title":"[Pathologically complete response for unresectable stage IV rectal cancer using systemic chemotherapy with panitumumab - a case report]","volume":"39","author":"Bamba","year":"2012","journal-title":"Gan To Kagaku Ryoho"},{"issue":"11","key":"10.1016\/j.critrevonc.2018.12.007_bib0050","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/0959-8049(93)90288-Q","article-title":"Laser surgery for small perianal neoplasms","volume":"29A","author":"Bandieramonte","year":"1993","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2018.12.007_bib0055","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijrobp.2010.05.050","article-title":"Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography\/computed tomography for staging and radiotherapy planning in patients with anal cancer","volume":"81","author":"Bannas","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0060","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000341371","article-title":"Efficacy of Cetuximab in combination with FOLFIRI in a patient with KRAS wild-type metastatic anal Cancer","volume":"5","author":"Barmettler","year":"2012","journal-title":"Case Rep. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.12.007_bib0065","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.critrevonc.2018.12.007_bib0070","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1002\/cncr.25901","article-title":"Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal","volume":"117","author":"Bazan","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0075","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1200\/JCO.2010.29.1351","article-title":"Impact of overall treatment time on survival and local control in patients with anal Cancer: a pooled data analysis of radiation therapy oncology group trials 87-04 and 98-11","volume":"28","author":"Ben-Josef","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.12.007_bib0080","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/0284186X.2013.770599","article-title":"Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors","volume":"52","author":"Bentzen","year":"2013","journal-title":"Acta Oncol."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0085","volume":"vol. 3","year":"2010"},{"issue":"5","key":"10.1016\/j.critrevonc.2018.12.007_bib0090","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1097\/00126334-200412150-00004","article-title":"HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?","volume":"37","author":"Bower","year":"2004","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092071","article-title":"KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC)","volume":"9","author":"Casadei Gardini","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.12.007_bib0100","doi-asserted-by":"crossref","first-page":"e607","DOI":"10.1016\/j.ijrobp.2011.02.042","article-title":"Long-term follow-up of a Phase II trial of high-dose radiation with concurrent 5-fluorouracil and cisplatin in patients with anal cancer (ECOG E4292)","volume":"81","author":"Chakravarthy","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.12.007_bib0105","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ijrobp.2005.05.047","article-title":"Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer","volume":"63","author":"Chapet","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.12.007_bib0110","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.qai.0000159669.80207.12","article-title":"A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic","volume":"40","author":"Chiao","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.12.007_bib0115","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/505219","article-title":"Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review","volume":"43","author":"Chiao","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.12.007_bib0120","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1200\/JCO.2007.14.2810","article-title":"Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era","volume":"26","author":"Chiao","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.12.007_bib0125","first-page":"39","article-title":"Intensity-modulated radiation therapy vs. 3D conformal radiation therapy for squamous cell carcinoma of the anal canal","volume":"6","author":"Chuong","year":"2013","journal-title":"Gastrointest. Cancer Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.12.007_bib0130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.brachy.2012.11.003","article-title":"High-dose-rate endorectal brachytherapy for locally advanced rectal cancer in previously irradiated patients","volume":"12","author":"Chuong","year":"2013","journal-title":"Brachytherapy"},{"issue":"3","key":"10.1016\/j.critrevonc.2018.12.007_bib0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1470-2045(04)01410-X","article-title":"Cancer of the anal canal","volume":"5","author":"Clark","year":"2004","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.12.007_bib0140","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ijrobp.2006.01.009","article-title":"FDG-PET\/CT in the evaluation of anal carcinoma","volume":"65","author":"Cotter","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.12.007_bib0145","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0090-4295(99)80458-0","article-title":"Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient\u2019s perspective","volume":"47","author":"Crook","year":"1996","journal-title":"Urology"},{"issue":"1-2","key":"10.1016\/j.critrevonc.2018.12.007_bib0150","first-page":"5","article-title":"Metastatic anal cancer: the search for cure","volume":"29","author":"Cummings","year":"2006","journal-title":"Onkologie"},{"issue":"5","key":"10.1016\/j.critrevonc.2018.12.007_bib0155","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/0360-3016(91)90265-6","article-title":"Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin","volume":"21","author":"Cummings","year":"1991","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2018.12.007_bib0160","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000227248","article-title":"Mitomycin in anal canal carcinoma","volume":"50","author":"Cummings","year":"1993","journal-title":"Oncology"},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0165","first-page":"515","article-title":"The treatment of anal carcinoma by interstitial irradiation","volume":"85","author":"Dalby","year":"1961","journal-title":"Am. J. Roentgenol. Radium Ther. Nucl. Med."},{"issue":"16","key":"10.1016\/j.critrevonc.2018.12.007_bib0170","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM198710153171601","article-title":"Sexual practices, sexually transmitted diseases, and the incidence of anal cancer","volume":"317","author":"Daling","year":"1987","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.12.007_bib0175","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/oxfordjournals.aje.a116270","article-title":"Cigarette smoking and the risk of anogenital cancer","volume":"135","author":"Daling","year":"1992","journal-title":"Am. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.12.007_bib0180","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/cncr.20365","article-title":"Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer","volume":"101","author":"Daling","year":"2004","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2018.12.007_bib0185","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/PGP.0b013e31826916c7","article-title":"The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the college of american pathologists and the american society for colposcopy and cervical pathology","volume":"32","author":"Darragh","year":"2013","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.12.007_bib0190","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/cncr.24906","article-title":"Long-term quality of life after radiotherapy for the treatment of anal cancer","volume":"116","author":"Das","year":"2010","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2018.12.007_bib0195","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.radonc.2013.03.012","article-title":"Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: a propensity score analysis","volume":"107","author":"Dasgupta","year":"2013","journal-title":"Radiother. Oncol."},{"issue":"44","key":"10.1016\/j.critrevonc.2018.12.007_bib0200","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.3748\/wjg.v18.i44.6349","article-title":"New approach to anal cancer: individualized therapy based on sentinel lymph node biopsy","volume":"18","author":"De Nardi","year":"2012","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.12.007_bib0205","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0360-3016(03)00417-6","article-title":"Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal","volume":"56","author":"Deniaud-Alexandre","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"8","key":"10.1016\/j.critrevonc.2018.12.007_bib0210","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.canrad.2006.09.116","article-title":"Carcinomes \u00e9pidermo\u00efdes du canal anal trait\u00e9s par association concomitante de radioth\u00e9rapie et de chimioth\u00e9rapie. \u00c9valuation des r\u00e9sultats fonctionnels","volume":"10","author":"Deniaud-Alexandre","year":"2006","journal-title":"Cancer\/Radioth\u00e9rapie"},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0215","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1748-717X-7-201","article-title":"Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?","volume":"7","author":"Dewas","year":"2012","journal-title":"Radiat. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2018.12.007_bib0220","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.1996.14.12.3121","article-title":"Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients","volume":"14","author":"Doci","year":"1996","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.12.007_bib0225","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.amjsurg.2011.01.015","article-title":"Outcomes of salvage surgery for epidermoid carcinoma of the anus following failed combined modality treatment","volume":"201","author":"Eason","year":"2011","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0230","first-page":"861","article-title":"5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer","volume":"86","author":"Faivre","year":"1999","journal-title":"Bull. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2018.12.007_bib0235","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.ejca.2011.10.038","article-title":"Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002","volume":"48","author":"Faivre","year":"2012","journal-title":"Eur. J. Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2018.12.007_bib0240","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J. Clin. Oncol."},{"issue":"Suppl 5","key":"10.1016\/j.critrevonc.2018.12.007_bib0245","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","author":"Forman","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.critrevonc.2018.12.007_bib0250","first-page":"194","article-title":"On the etiology of anal squamous carcinoma","volume":"49","author":"Frisch","year":"2002","journal-title":"Dan. Med. Bull."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.12.007_bib0255","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1056\/NEJM199408043310504","article-title":"Benign anal lesions and the risk of anal cancer","volume":"331","author":"Frisch","year":"1994","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.12.007_bib0260","first-page":"753","article-title":"Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses","volume":"59","author":"Frisch","year":"1999","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.12.007_bib0265","first-page":"139","article-title":"Squamous-cell carcinoma of the anus and anal canal: an analysis of 55 cases: (Section of Proctology)","volume":"34","author":"Gabriel","year":"1941","journal-title":"Proc. R. Soc. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.12.007_bib0270","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1016\/j.ijrobp.2012.01.023","article-title":"Pelvic normal tissue contouring guidelines for radiation therapy: a radiation therapy oncology group consensus panel atlas","volume":"83","author":"Gay","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.12.007_bib0275","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0167-8140(97)00192-8","article-title":"Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients","volume":"46","author":"Gerard","year":"1998","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.12.007_bib0280","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/1097-0142(20010701)92:1<77::AID-CNCR1294>3.0.CO;2-P","article-title":"Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature","volume":"92","author":"Gerard","year":"2001","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2018.12.007_bib0285","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.ijrobp.2010.10.017","article-title":"Anal cancer: an examination of radiotherapy strategies","volume":"79","author":"Glynne-Jones","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.12.007_bib0290","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijrobp.2007.12.012","article-title":"EXTRA \u2013 a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer","volume":"72","author":"Glynne-Jones","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"No. 5","key":"10.1016\/j.critrevonc.2018.12.007_bib0295","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.ijrobp.2010.07.1995","article-title":"\u201cMind the gap\u2019\u2019\u2014the impact of variations in the duration of the treatment gap and overall treatment time in the first uk anal Cancer trial (Act I)","volume":"81","author":"Glynne-Jones","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"8","key":"10.1016\/j.critrevonc.2018.12.007_bib0300","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/annonc\/mdu188","article-title":"Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial","volume":"25","author":"Glynne-Jones","year":"2014","journal-title":"Ann. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2018.12.007_bib0305","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/DCR.0b013e318227833e","article-title":"Long-term follow-up of infrared coagulator ablation of anal high-grade dysplasia in men who have sex with men","volume":"54","author":"Goldstone","year":"2011","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0310","first-page":"163736","article-title":"A regimen of taxol, Ifosfamide, and platinum for recurrent advanced squamous cell cancer of the anal canal","volume":"2011","author":"Golub","year":"2011","journal-title":"Chemother. Res. Pract."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0315","article-title":"Programmed cell death-ligand 1 (PD-L1) expression in anal Cancer","author":"Govindarajan","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.12.007_bib0320","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF02235757","article-title":"Sphincter preservation with chemoradiation in anal canal carcinoma: abdominoperineal resection in selected cases?","volume":"41","author":"Grabenbauer","year":"1998","journal-title":"Dis. Colon Rectum"},{"issue":"35","key":"10.1016\/j.critrevonc.2018.12.007_bib0325","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2018.12.007_bib0330","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.ejca.2008.02.013","article-title":"Cancer screening: evidence and practice in Europe 2008","volume":"44","author":"Hakama","year":"2008","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2018.12.007_bib0335","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijrobp.2013.01.034","article-title":"RTOG 0529: Intensity modulated radiation therapy and anal cancer, a step in the right direction?","volume":"86","author":"Herman","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"22","key":"10.1016\/j.critrevonc.2018.12.007_bib0340","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/jnci\/81.22.1726","article-title":"Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking","volume":"81","author":"Holly","year":"1989","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.12.007_bib0345","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0016-5085(88)90297-1","article-title":"Anal cancer in women","volume":"95","author":"Holmes","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0350","series-title":"SEER Cancer Statistics Review, 1975-2006","year":"2009"},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0355","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00000421-199312000-00017","article-title":"Cisplatin and 5-fluorouracil as salvage therapy for recurrent metastatic squamous cell carcinoma of the anal canal","volume":"16","author":"Jaiyesimi","year":"1993","journal-title":"Am. J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2018.12.007_bib0360","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 x 2 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0365","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pvr.2015.06.004","article-title":"Colposcopic characteristics and Lugol\u2019s staining differentiate anal high-grade and low-grade squamous intraepithelial lesions during high resolution anoscopy","volume":"1","author":"Jay","year":"2015","journal-title":"Papillomavirus Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.12.007_bib0370","first-page":"205","article-title":"Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08","volume":"2","author":"John","year":"1996","journal-title":"Cancer J. Sci. Am."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0375","first-page":"205","article-title":"Dose-escalation in chemoradiation for anal cancer: preliminary results of RTOG 9208","volume":"2","author":"John","year":"1996","journal-title":"Cancer J. Sci. Am."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0380","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12885-015-1244-7","article-title":"Multiparametric MRI as an outcome predictor for anal canal cancer managed with chemoradiotherapy","volume":"15","author":"Jones","year":"2015","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2018.12.007_bib0385","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0390","first-page":"1345","article-title":"Cisplatin plus 5-fluorouracil in the treatment of metastatic anal squamous cell carcinoma: a report of two cases","volume":"70","author":"Khater","year":"1986","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0395","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1093\/annonc\/mdt396","article-title":"DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinoma","volume":"24","author":"Kim","year":"2013","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2018.12.007_bib0400","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/(SICI)1097-0142(19990415)85:8<1686::AID-CNCR7>3.0.CO;2-7","article-title":"Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes","volume":"85","author":"Klas","year":"1999","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2018.12.007_bib0405","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0889-8588(03)00039-X","article-title":"Anal cancer: an HIV-associated cancer","volume":"17","author":"Klencke","year":"2003","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0410","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijrobp.2007.12.027","article-title":"Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08","volume":"72","author":"Konski","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.12.007_bib0415","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/0969141314522454","article-title":"Condom use in prevention of Human Papillomavirus infections and cervical neoplasia: systematic review of longitudinal studies","volume":"21","author":"Lam","year":"2014","journal-title":"J. Med. Screen."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.12.007_bib0420","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0002-9343(85)90428-0","article-title":"Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy","volume":"78","author":"Leichman","year":"1985","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.12.007_bib0425","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s12032-012-0402-x","article-title":"Radiochemotherapy and brachytherapy could be the standard treatment for anal canal cancer in elderly patients? A retrospective single-centre analysis","volume":"30","author":"Lestrade","year":"2013","journal-title":"Med. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.12.007_bib0430","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1258\/ijsa.2011.011020","article-title":"Evaluation of the impact of HIV serostatus, tobacco smoking and CD4 counts on epidermoid anal cancer survival","volume":"23","author":"Linam","year":"2012","journal-title":"Int. J. STD AIDS"},{"issue":"5","key":"10.1016\/j.critrevonc.2018.12.007_bib0435","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1470-2045(12)70080-3","article-title":"Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis","volume":"13","author":"Machalek","year":"2012","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.12.007_bib0440","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/QAI.0b013e3182437469","article-title":"Electrocautery ablation of high-grade anal squamous intraepithelial lesions in HIV-negative and HIV-positive men who have sex with men","volume":"59","author":"Marks","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.12.007_bib0445","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0960-7404(96)80019-3","article-title":"Squamous cell carcinoma of the anal margin treated with radiotherapy","volume":"5","author":"Mendenhall","year":"1996","journal-title":"Surg. Oncol."},{"issue":"19","key":"10.1016\/j.critrevonc.2018.12.007_bib0450","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1200\/JCO.2008.16.2339","article-title":"Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281)","volume":"26","author":"Meropol","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.12.007_bib0455","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijrobp.2005.02.030","article-title":"Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome","volume":"63","author":"Milano","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.12.007_bib0460","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijrobp.2009.04.020","article-title":"Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer","volume":"77","author":"Mistrangelo","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.12.007_bib0465","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijrobp.2011.10.048","article-title":"Role of positron emission tomography-computed tomography in the management of anal cancer","volume":"84","author":"Mistrangelo","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.12.007_bib0470","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/bjc.2012.600","article-title":"Value of staging squamous cell carcinoma of the anal margin and canal using the sentinel lymph node procedure: an update of the series and a review of the literature","volume":"108","author":"Mistrangelo","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2018.12.007_bib0475","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/COC.0b013e31827e52a3","article-title":"Intensity-modulated radiation therapy with concurrent chemotherapy for anal cancer: outcomes and toxicity","volume":"37","author":"Mitchell","year":"2014","journal-title":"Am. J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.12.007_bib0480","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/j.ijrobp.2012.09.034","article-title":"Role of brachytherapy in the boost management of anal carcinoma with node involvement (CORS-03 study)","volume":"85","author":"Moureau-Zabotto","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.12.007_bib0485","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1245\/s10434-006-9221-7","article-title":"Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal","volume":"14","author":"Mullen","year":"2007","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.12.007_bib0490","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","article-title":"Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas","volume":"74","author":"Myerson","year":"2009","journal-title":"Int. J. Radiation Oncology Biol. Phys"},{"issue":"5","key":"10.1016\/j.critrevonc.2018.12.007_bib0495","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijrobp.2011.12.058","article-title":"Australasian gastrointestinal trials group (AGITG) contouring atlas and planning guidelines for intensity- modulated radiotherapy in anal Cancer","volume":"83","author":"Ng","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.12.007_bib0500","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijrobp.2011.12.058","article-title":"(AGITG)","volume":"83","author":"Ng","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.12.007_bib0505","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF02586980","article-title":"Combined therapy for cancer of the anal canal: a preliminary report","volume":"17","author":"Nigro","year":"1974","journal-title":"Dis. Colon Rectum"},{"issue":"11","key":"10.1016\/j.critrevonc.2018.12.007_bib0510","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1046\/j.1365-2168.2002.02231.x","article-title":"Salvage abdominoperineal resection in anal epidermoid cancer","volume":"89","author":"Nilsson","year":"2002","journal-title":"Br. J. Surg."},{"issue":"7","key":"10.1016\/j.critrevonc.2018.12.007_bib0515","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2018.12.007_bib0520","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.ijrobp.2011.02.010","article-title":"Anal canal cancer: management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 Study)","volume":"82","author":"Ortholan","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"issue":"May (5)","key":"10.1016\/j.critrevonc.2018.12.007_bib0525","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/annonc\/mdx029","article-title":"Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal","volume":"28","author":"Ott","year":"2017","journal-title":"J. Ann. Oncol"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.12.007_bib0530","first-page":"415","article-title":"Molecular virology and epidemiology of human papillomavirus and cervical cancer","volume":"4","author":"Palefsky","year":"1995","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0535","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2018.12.007_bib0540","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/0360-3016(89)90521-X","article-title":"Interstitial curietherapy in the conservative treatment of anal and rectal cancers","volume":"17","author":"Papillon","year":"1989","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"12","key":"10.1016\/j.critrevonc.2018.12.007_bib0545","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"1941","key":"10.1016\/j.critrevonc.2018.12.007_bib0550","first-page":"2012","article-title":"Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial","volume":"30","author":"Peiffert","year":"1948","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.12.007_bib0555","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0360-3016(96)00493-2","article-title":"Conservative treatment by irradiation of epidermoid cancers of the anal canal: prognostic factors of tumoral control and complications","volume":"37","author":"Peiffert","year":"1997","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.12.007_bib0560","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1023\/A:1011107105538","article-title":"High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study","volume":"12","author":"Peiffert","year":"2001","journal-title":"Ann. Oncol."},{"issue":"16","key":"10.1016\/j.critrevonc.2018.12.007_bib0565","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","article-title":"Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial","volume":"30","author":"Peiffert","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.12.007_bib0570","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.mrgentox.2004.02.014","article-title":"Smoking-related DNA adducts in anal epithelium","volume":"560","author":"Phillips","year":"2004","journal-title":"Mutat. Res."},{"issue":"12","key":"10.1016\/j.critrevonc.2018.12.007_bib0575","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/BF02237294","article-title":"Results of salvage abdominoperineal resection for anal cancer after radiotherapy","volume":"41","author":"Pocard","year":"1998","journal-title":"Dis. Colon Rectum"},{"issue":"1","key":"10.1016\/j.critrevonc.2018.12.007_bib0580","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/oxfordjournals.aje.a116420","article-title":"Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors","volume":"136","author":"Rabkin","year":"1992","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.12.007_bib0585","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.scrs.2013.09.008","article-title":"Late effects of pelvic radiation for rectal cancer and implications for survivorship","volume":"25","author":"Rao","year":"2014","journal-title":"Semin. Colon Rectal Surg."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0590","unstructured":"RARECAREnet Project: http:\/\/www.rarecarenet.eu\/rarecarenet\/."},{"issue":"5","key":"10.1016\/j.critrevonc.2018.12.007_bib0595","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/bjs.4908","article-title":"Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer","volume":"92","author":"Renehan","year":"2005","journal-title":"Br. J. Surg."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.12.007_bib0600","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1470-2045(13)70067-6","article-title":"Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial","volume":"14","author":"Richel","year":"2013","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.12.007_bib0605","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10350-007-9125-z","article-title":"Squamous-cell carcinoma of the anal canal: predictor of treatment outcome","volume":"51","author":"Roohipour","year":"2008","journal-title":"Dis. Colon Rectum"},{"issue":"3","key":"10.1016\/j.critrevonc.2018.12.007_bib0610","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.suronc.2005.07.002","article-title":"Sqamous cell carcinoma of the anal canal","volume":"14","author":"Rousseau","year":"2005","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0615","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11060-010-0218-5","article-title":"Anal cancer with cerebral metastasis: a case report","volume":"101","author":"Rughani","year":"2011","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0620","series-title":"American Cancer Society Atlas of Clinical Oncology: Cancer of the Lower Gastrointestinal Tract","first-page":"196","article-title":"Anal cancer","author":"Ryan","year":"2001"},{"issue":"11","key":"10.1016\/j.critrevonc.2018.12.007_bib0625","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM200003163421107","article-title":"Carcinoma of the anal canal","volume":"342","author":"Ryan","year":"2000","journal-title":"N. Eng. J. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.12.007_bib0630","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.radonc.2008.04.011","article-title":"The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer","volume":"87","author":"Saarilahti","year":"2008","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0635","series-title":"Evidence-based Medicine","author":"Sackett","year":"2000"},{"issue":"6","key":"10.1016\/j.critrevonc.2018.12.007_bib0640","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s10350-004-0934-z","article-title":"Management of anal canal cancer","volume":"48","author":"Sato","year":"2005","journal-title":"Dis. Colon Rectum"},{"issue":"10","key":"10.1016\/j.critrevonc.2018.12.007_bib0645","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1245\/s10434-007-9491-8","article-title":"Outcomes of salvage surgery for squamous cell carcinoma of the anal canal","volume":"14","author":"Schiller","year":"2007","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0650","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-3-642-80035-1_16","article-title":"Current aspects of sphincter preservation in the surgical therapy of rectal cancer","volume":"142","author":"Schlag","year":"1996","journal-title":"Recent Results Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.12.007_bib0655","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijrobp.2007.09.005","article-title":"Tumor response and survival predicted by post-therapy FDG-PET\/CT in anal cancer","volume":"71","author":"Schwarz","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0660","unstructured":"SEER database: http:\/\/seer.cancer.gov\/statfacts\/html\/pancreas.html."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.12.007_bib0665","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/QAI.0b013e3182a9b3d3","article-title":"Random biopsy during high-resolution anoscopy increases diagnosis of anal high-grade squamous intraepithelial lesions","volume":"65","author":"Silvera","year":"2014","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"1","key":"10.1016\/j.critrevonc.2018.12.007_bib0670","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/028418601750071028","article-title":"Management of persistent or locally recurrent epidermoid cancer of the anal canal with abdominoperineal resection","volume":"40","author":"Smith","year":"2001","journal-title":"Acta Oncol."},{"issue":"16","key":"10.1016\/j.critrevonc.2018.12.007_bib0675","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.critrevonc.2018.12.007_bib0680","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1245\/s10434-008-0208-4","article-title":"Perineal healing and survival after anal cancer salvage surgery: 10-year experience with primary perineal reconstruction using the vertical rectus abdominis myocutaneous (VRAM) flap","volume":"16","author":"Sunesen","year":"2009","journal-title":"Ann. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2018.12.007_bib0685","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0360-3016(98)00122-9","article-title":"Induction chemotherapy and radiotherapy in loco-regionally advanced epidermoid carcinoma of the anal canal","volume":"41","author":"Svensson","year":"1998","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0690","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/02841869309083882","article-title":"Treatment of relapsing anal carcinoma","volume":"32","author":"Tanum","year":"1993","journal-title":"Acta Oncol."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0695","first-page":"30","article-title":"Combined multimodal approach to the treatment of metastatic anal carcinoma: report of a case and review of the literature","volume":"29","author":"Tokar","year":"2006","journal-title":"Onkologie"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.12.007_bib0700","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11307-005-0003-6","article-title":"Positron Emission Tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal","volume":"7","author":"Trautmann","year":"2005","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0705","series-title":"TMN Classification of Malignant Tumor","author":"Union for Internation Cancer Control","year":"2002"},{"issue":"5","key":"10.1016\/j.critrevonc.2018.12.007_bib0710","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1634\/theoncologist.12-5-524","article-title":"Anal cancer: an overview","volume":"12","author":"Uronis","year":"2007","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.critrevonc.2018.12.007_bib0715","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1091-255X(01)80066-4","article-title":"Results of salvage abdominoperineal resection for recurrent anal carcinoma following combined chemoradiation therapy","volume":"5","author":"van der Wal","year":"2001","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.critrevonc.2018.12.007_bib0720","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.humpath.2009.05.010","article-title":"Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus","volume":"40","author":"Walker","year":"2009","journal-title":"Hum. Pathol."},{"issue":"3","key":"10.1016\/j.critrevonc.2018.12.007_bib0725","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00066-010-2175-5","article-title":"Quality of life outcomes in patients with anal cancer after combined radiochemotherapy","volume":"187","author":"Welzel","year":"2011","journal-title":"Strahlenther. Onkol."},{"issue":"2","key":"10.1016\/j.critrevonc.2018.12.007_bib0730","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1310\/hct1402-75","article-title":"High-grade anal intraepithelial neoplasia among HIV-1-infected men screening for a multicenter clinical trial of a human papillomavirus vaccine","volume":"14","author":"Wilkin","year":"2013","journal-title":"HIV Clin. Trials"},{"issue":"1","key":"10.1016\/j.critrevonc.2018.12.007_bib0735","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF02053864","article-title":"Wide resection and reconstruction preserving fecal continence in recurrent anal cancer. Report of three cases","volume":"38","author":"Zoetmulder","year":"1995","journal-title":"Dis. Colon Rectum"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842817302408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842817302408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:30:13Z","timestamp":1760902213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842817302408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":147,"alternative-id":["S1040842817302408"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2018.12.007","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer of the anal region","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2018.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}